Blue Buffalo Pet Products, Inc. (NASDAQ:BUFF)‘s stock had its “buy” rating reissued by analysts at Barclays PLC in a research note issued on Friday. They presently have a $27.00 price target on the stock. Barclays PLC’s target price suggests a potential upside of 13.92% from the company’s previous close.

Other research analysts also recently issued reports about the company. Imperial Capital assumed coverage on Blue Buffalo Pet Products in a report on Wednesday, June 28th. They set an “outperform” rating and a $30.00 price target on the stock. Oppenheimer Holdings, Inc. reaffirmed an “outperform” rating and set a $25.00 price target (down from $29.00) on shares of Blue Buffalo Pet Products in a report on Thursday. Zacks Investment Research raised Blue Buffalo Pet Products from a “sell” rating to a “hold” rating in a report on Thursday. BidaskClub downgraded Blue Buffalo Pet Products from a “sell” rating to a “strong sell” rating in a report on Tuesday, July 11th. Finally, Susquehanna Bancshares Inc reaffirmed a “buy” rating and set a $30.00 price target (down from $32.00) on shares of Blue Buffalo Pet Products in a report on Monday. Two analysts have rated the stock with a sell rating, three have given a hold rating, seven have given a buy rating and one has assigned a strong buy rating to the company. The stock has an average rating of “Buy” and a consensus price target of $27.64.

Blue Buffalo Pet Products (BUFF) traded up 5.10% during midday trading on Friday, hitting $23.70. The stock had a trading volume of 2,561,578 shares. The firm has a 50 day moving average of $22.58 and a 200 day moving average of $23.71. Blue Buffalo Pet Products has a 52 week low of $21.51 and a 52 week high of $26.74. The firm has a market cap of $4.67 billion, a price-to-earnings ratio of 33.38 and a beta of 1.95.

Blue Buffalo Pet Products (NASDAQ:BUFF) last released its earnings results on Tuesday, August 8th. The company reported $0.21 EPS for the quarter, hitting analysts’ consensus estimates of $0.21. Blue Buffalo Pet Products had a return on equity of 112.54% and a net margin of 12.13%. The firm had revenue of $294.80 million for the quarter, compared to analysts’ expectations of $301.88 million. During the same period in the prior year, the firm posted $0.19 earnings per share. The company’s quarterly revenue was up 2.8% on a year-over-year basis. Equities research analysts predict that Blue Buffalo Pet Products will post $0.92 EPS for the current year.

Blue Buffalo Pet Products declared that its board has authorized a share repurchase plan on Tuesday, August 8th that permits the company to repurchase $50.00 million in outstanding shares. This repurchase authorization permits the company to reacquire up to 1.2% of its shares through open market purchases. Shares repurchase plans are typically an indication that the company’s board believes its shares are undervalued.

ILLEGAL ACTIVITY NOTICE: This news story was posted by Daily Political and is the sole property of of Daily Political. If you are reading this news story on another publication, it was illegally copied and reposted in violation of U.S. and international copyright and trademark law. The legal version of this news story can be read at https://www.dailypolitical.com/2017/08/11/barclays-plc-reaffirms-buy-rating-for-blue-buffalo-pet-products-inc-nasdaqbuff.html.

A number of hedge funds and other institutional investors have recently bought and sold shares of the stock. Principal Financial Group Inc. increased its position in Blue Buffalo Pet Products by 0.4% in the first quarter. Principal Financial Group Inc. now owns 13,046 shares of the company’s stock worth $300,000 after buying an additional 56 shares in the last quarter. NGAM Advisors L.P. increased its position in Blue Buffalo Pet Products by 0.4% in the second quarter. NGAM Advisors L.P. now owns 27,961 shares of the company’s stock worth $638,000 after buying an additional 105 shares in the last quarter. ETRADE Capital Management LLC increased its position in Blue Buffalo Pet Products by 0.4% in the second quarter. ETRADE Capital Management LLC now owns 32,243 shares of the company’s stock worth $735,000 after buying an additional 114 shares in the last quarter. Advisor Group Inc. increased its position in Blue Buffalo Pet Products by 6.5% in the second quarter. Advisor Group Inc. now owns 4,513 shares of the company’s stock worth $103,000 after buying an additional 277 shares in the last quarter. Finally, Argent Capital Management LLC increased its position in Blue Buffalo Pet Products by 2.5% in the first quarter. Argent Capital Management LLC now owns 20,780 shares of the company’s stock worth $478,000 after buying an additional 500 shares in the last quarter. 88.92% of the stock is currently owned by institutional investors.

Blue Buffalo Pet Products Company Profile

Blue Buffalo Pet Products, Inc (BBPP) is a holding company. The Company operates as a pet food company. The Company, through its subsidiaries, develops, produces, markets and sells pet food under product lines, including BLUE Life Protection Formula, BLUE Wilderness, BLUE Basics, BLUE Freedom and BLUE Natural Veterinary Diet lines.

Analyst Recommendations for Blue Buffalo Pet Products (NASDAQ:BUFF)

Receive News & Ratings for Blue Buffalo Pet Products Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Blue Buffalo Pet Products Inc. and related companies with MarketBeat.com's FREE daily email newsletter.